HOME » 所属検索 » 研究者名リスト (医学部・医学系研究科・附属病院) » Gabazza Sanabria Esteban Cesar 詳細
世界でメイク・ア・ディファレンス(make a difference)のスローガンで他施設または企業と共同研究したい。
※画像をクリックすると拡大します。
●製薬会社との共同研究で新薬の開発
●ベンチャー企業との共同研究で研究用試薬の開発
●WO2006/041808 A2肺線維症治療剤
●特開2004-035511 新規な気管支喘息治療剤
●特願2011-237166 ヒトTGFb1を発現するトランジェニックマウス
●US20060105995A1 TAFI inhibitors and their use to treat pulmonary fibrosis
●JP2011/073628 Profilactic or therapeutic agent for fibrosis
●JP2002000197729 New therapeutic agent for bronchial asthma
●米国胸部疾患学会(American Thoracic Society)会員
欧州呼吸器疾患学会(European Respiratory Society)会員
●米国アレルギー・喘息免疫学会(American College of Allergy, Asthma and Immunology)会員
●英国免疫学会(British Society of Immunology)会員
●日本免疫学会 会員
●日本アレルギー学会 会員
●日本呼吸器疾患学会 会員
●日本文部科学省奨学金(6年間半)1987
●アスシオン国立大学優秀卒業生賞 金メダル取得 1984
●Boveda-Ruiz D, D'Alessandro-Gabazza CN, Toda M, Takagi T, Naito M, Matsushima Y, Matsumoto T, Kobayashi T, Gil-Bernabe P, Chelakkot-Govindalayathil AL, Miyake Y, Yasukawa A, Morser J, Taguchi O, Gabazza EC. Differential role of regulatory T cells in early and late stages of pulmonary fibrosis. Immunobiology. 2012 May 23.
●Eagan TM, Gabazza EC, D Alessandro-Gabazza C, Gil-Bernabe P, Aoki S, Hardie JA, Bakke PS, Wagner PD. TNF-alpha is associated with loss of lean body mass only in already cachectic COPD patients. Respir Res. 2012 Jun 18;13(1):48.
●Gil-Bernabe P, D'Alessandro-Gabazza CN, Toda M, Boveda Ruiz D, Miyake Y, Suzuki T, Onishi Y, Morser J, Gabazza EC, Takei Y, Yano Y. Exogenous activated protein C inhibits the progression of diabetic nephropathy. J Thromb Haemost. 2012 Mar;10(3):337-46.
●D'Alessandro-Gabazza CN, Kobayashi T, Boveda-Ruiz D, Takagi T, Toda M, Gil-Bernabe P, Miyake Y, Yasukawa A, Matsuda Y, Suzuki N, Saito H, Yano Y, Fukuda A, Hasegawa T, Toyobuku H, Rennard SI, Wagner PD, Morser J, Takei Y, Taguchi O, Gabazza EC. Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis. Am J Respir Cell Mol Biol. 2012 Mar;46(3):397-406.
●Gil-Bernabe P, Boveda-Ruiz D, D'Alessandro-Gabazza C, Toda M, Miyake Y, Mifuji-Moroka R, Iwasa M, Morser J, Gabazza EC, Takei Y. Atherosclerosis amelioration by moderate alcohol consumption is associated with increased circulating levels of stromal cell-derived factor-1. Circ J. 2011;75(9):2269-79.
●Takagi T, Taguchi O, Toda M, Ruiz DB, Bernabe PG, D'Alessandro-Gabazza CN, Miyake Y, Kobayashi T, Aoki S, Chiba F, Yano Y, Conway EM, Munesue S, Yamamoto Y, Yamamoto H, Suzuki K, Takei Y, Morser J, Gabazza EC. Inhibition of allergic bronchial asthma by thrombomodulin is mediated by dendritic cells. Am J Respir Crit Care Med. 2011 Jan 1;183(1):31-42.
●Beppu T, Gil-Bernabe P, Boveda-Ruiz D, D'Alessandro-Gabazza C, Matsuda Y, Toda M, Miyake Y, Shiraki K, Murata M, Murata T, Yano Y, Morser J, Gabazza EC, Takei Y. High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient mice. Thromb Haemost. 2010 Nov;8(11):2514-22.
●Maruyama T, Taguchi O, Niederman MS, Morser J, Kobayashi H, Kobayashi T, D'Alessandro-Gabazza C, Nakayama S, Nishikubo K, Noguchi T, Takei Y, Gabazza EC Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial. BMJ. 2010 Mar 8;340:c1004.
●Morser J, Gabazza EC, Myles T, Leung LL. What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse? J Thromb Haemost. 2010 May;8(5):868-76.
●Qin L, D'Alessandro-Gabazza CN, Aoki S, Gil-Bernabe P, Yano Y, Takagi T, Boveda-Ruiz D, Ramirez Marmol AY, San Martin Montenegro VT, Toda M, Miyake Y, Taguchi O, Takei Y, Morser J, Gabazza EC. Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor. J Thromb Haemost. 2010 Apr;8(4):808-16.